Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06477952
PHASE1/PHASE2

DRonabinol Treatment of OSA

Sponsor: VA Office of Research and Development

View on ClinicalTrials.gov

Summary

This is an open-label trial that tests the effectiveness of Dronabinol in treating obstructive sleep apnea (OSA). All participants will take oral Dronabinol for two weeks. Sleep studies will be conducted before and after treatment to measure OSA severity.

Official title: Targeted Treatment of Obstructive Sleep Apnea With Dronabinol: Proof of Concept and Phase II Clinical Trial

Key Details

Gender

All

Age Range

Any - 65 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-08-25

Completion Date

2026-12-31

Last Updated

2025-09-12

Healthy Volunteers

No

Interventions

DRUG

Dronabinol

Open label Dronabinol treatment for two weeks.

Locations (1)

Jesse Brown VA Medical Center, Chicago, IL

Chicago, Illinois, United States